Compare Abbott Laboratories (ABT) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs SoFi Technologies Inc — how do they compare? Abbott Laboratories trades at $95.13 (market cap $166.94B), while SoFi Technologies Inc trades at $17.7 (market cap $22.77B). The key difference: Abbott Laboratories is far larger — about 7.3× SoFi Technologies Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals.
| ABT | SOFI | |
|---|---|---|
Market Cap | $166.94B | $22.77B |
Sector | Health | Financials |
52-Week High | $136.62 | $32.21 |
52-Week Low | $82.57 | $15.15 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
SOFI stock trades at $17.75, down 2.69% on the day, with a bullish technical signal and strong support at $17. The company reported revenue growth to $3.61B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion into small business loans and AI-driven products like Coach and Composer, aiming to deepen member engagement.
Outlook remains positive with a consensus price target of $21.22, offering 20% upside potential. Key risks include negative operating cash flow and high valuation multiples. Growth catalysts are centered on loan originations and ecosystem expansion, but investors should monitor execution and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
